Search

Your search keyword '"Vis, J Y"' showing total 18 results
Start Over Author "Vis, J Y"
18 results on '"Vis, J Y"'

2. Cost-effectiveness of Diagnostic Testing Strategies Including Cervical-Length Measurement and Fibronectin Testing in Women With Symptoms of Preterm Labor

Author

van Baaren, G.-J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C. J., Spaanderman, M. E. A., Bloemenkamp, K. W. M., Haak, M. C., Bax, C. J., Cornette, J. M. J., Duvekot, J. J., Nij Bijvanck, B. W. A., van Eyck, J., Franssen, M. T. M., Sollie, K. M., Vandenbussche, F. P. H. A., Woiski, M., Bolte, A. C., van der Post, J. A. M., Bossuyt, P. M. M., Opmeer, B. C., and Mol, B. W. J.

Published
2018
Full Text
View/download PDF

3. The Impact of a Standardized Pre-visit Laboratory Testing Panel in the Internal Medicine Outpatient Clinic:a Controlled “On-Off” Trial

Author

Vrijsen, B. E.L., ten Berg, M. J., Naaktgeboren, C. A., Vis, J. Y., Dijstelbloem, H. M., Westerink, J., Dekker, D., Hoefer, I. E., Haitjema, S., Hulsbergen-Veelken, C. A.R., van Solinge, W. W., Kaasjager, H. A.H., Vrijsen, B. E.L., ten Berg, M. J., Naaktgeboren, C. A., Vis, J. Y., Dijstelbloem, H. M., Westerink, J., Dekker, D., Hoefer, I. E., Haitjema, S., Hulsbergen-Veelken, C. A.R., van Solinge, W. W., and Kaasjager, H. A.H.

Abstract

Background: In several settings, a shorter time to diagnosis has been shown to lead to improved clinical outcomes. The implementation of a rapid laboratory testing allows for a pre-visit testing in the outpatient clinic, meaning that test results are available during the first outpatient visit. Objective: To determine whether the pre-visit laboratory testing leads to a shorter time to diagnosis in the general internal medicine outpatient clinic. Design: An “on-off” trial, allocating subjects to one of two treatment arms in consecutive alternating blocks. Participants: All new referrals to the internal medicine outpatient clinic of a university hospital were included, excluding second opinions. A total of 595 patients were eligible; one person declined to participate, leaving data from 594 patients for analysis. Intervention: In the intervention group, patients had a standardized pre-visit laboratory testing before the first visit. Main Measures: The primary outcome was the time to diagnosis. Secondary outcomes were the correctness of the preliminary diagnosis on the first day, health care utilization, and patient and physician satisfaction. Key Results: There was no difference in time to diagnosis between the two groups (median 35 days vs 35 days; hazard ratio 1.03 [0.87–1.22]; p =.71). The pre-visit testing group had higher proportions of both correct preliminary diagnoses on day 1 (24% vs 14%; p =.003) and diagnostic workups being completed on day 1 (10% vs 3%; p <.001). The intervention group had more laboratory tests done (50.0 [interquartile range (IQR) 39.0–69.0] vs 43.0 [IQR 31.0–68.5]; p <.001). Otherwise, there were no differences between the groups. Conclusions: Pre-visit testing did not lead to a shorter overall time to diagnosis. However, a greater proportion of patients had a correct diagnosis on the first day. Further studies should focus on customizing pre-visit laboratory panels, to improve their efficacy. Trial Registration: NL5009.

Published
2021

4. The Impact of a Standardized Pre-visit Laboratory Testing Panel in the Internal Medicine Outpatient Clinic: a Controlled 'On-Off' Trial

Author

MS Interne Geneeskunde, NVIC, CDL Staf Patiëntenzorg KC, Infection & Immunity, Epi Methoden Team 1, CDL Klinisch Chemici in opleiding, Circulatory Health, CDL Arcadia, CDL Upod, Centraal Diagnostisch Laboratorium, Vrijsen, B E L, Ten Berg, M J, Naaktgeboren, C A, Vis, J Y, Dijstelbloem, H M, Westerink, J, Dekker, D, Hoefer, I E, Haitjema, S, Hulsbergen-Veelken, C A R, van Solinge, W W, Kaasjager, H A H, MS Interne Geneeskunde, NVIC, CDL Staf Patiëntenzorg KC, Infection & Immunity, Epi Methoden Team 1, CDL Klinisch Chemici in opleiding, Circulatory Health, CDL Arcadia, CDL Upod, Centraal Diagnostisch Laboratorium, Vrijsen, B E L, Ten Berg, M J, Naaktgeboren, C A, Vis, J Y, Dijstelbloem, H M, Westerink, J, Dekker, D, Hoefer, I E, Haitjema, S, Hulsbergen-Veelken, C A R, van Solinge, W W, and Kaasjager, H A H

Published
2021

7. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor

Author

van Baaren, G.-J., primary, Vis, J. Y., additional, Wilms, F. F., additional, Oudijk, M. A., additional, Kwee, A., additional, Porath, M. M., additional, Scheepers, H. C. J., additional, Spaanderman, M. E. A., additional, Bloemenkamp, K. W. M., additional, Haak, M. C., additional, Bax, C. J., additional, Cornette, J. M. J., additional, Duvekot, J. J., additional, Nij Bijvanck, B. W. A., additional, van Eyck, J., additional, Franssen, M. T. M., additional, Sollie, K. M., additional, Vandenbussche, F. P. H. A., additional, Woiski, M., additional, Bolte, A. C., additional, van der Post, J. A. M., additional, Bossuyt, P. M. M., additional, Opmeer, B. C., additional, and Mol, B. W. J., additional

Published
2018
Full Text
View/download PDF

8. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor

Author

van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Mol, B. W.J., van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., and Mol, B. W.J.

Published
2018

9. Cost-effectiveness of diagnostic testing strategies including cervical-length measurement and fibronectin testing in women with symptoms of preterm labor

Author

UMC Utrecht, CDL Klinisch Chemici in opleiding, MS Verloskunde, Other research (not in main researchprogram), Geboortecentrum voorzitterschap, van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Mol, B. W.J., UMC Utrecht, CDL Klinisch Chemici in opleiding, MS Verloskunde, Other research (not in main researchprogram), Geboortecentrum voorzitterschap, van Baaren, G. J., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., Vandenbussche, F. P.H.A., Woiski, M., Bolte, A. C., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., and Mol, B. W.J.

Published
2018

11. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women

Author

Bruijn, Mmc, Vis, J Y, Wilms, F F, Oudijk, M A, Kwee, A, Porath, M M, Oei, G, Scheepers, Hcj, Spaanderman, Mea, Bloemenkamp, Kwm, Haak, M C, Bolte, A C, Vandenbussche, Fpha, Woiski, M D, Bax, C J, Cornette, Jmj, Duvekot, J J, Nij Bijvanck, Bwa, van Eyck, J, Franssen, Mtm, Sollie, K M, van der Post, Jam, Bossuyt, Pmm, Opmeer, B C, Kok, M., Mol, Bwj, van Baaren, G-J, Bruijn, Mmc, Vis, J Y, Wilms, F F, Oudijk, M A, Kwee, A, Porath, M M, Oei, G, Scheepers, Hcj, Spaanderman, Mea, Bloemenkamp, Kwm, Haak, M C, Bolte, A C, Vandenbussche, Fpha, Woiski, M D, Bax, C J, Cornette, Jmj, Duvekot, J J, Nij Bijvanck, Bwa, van Eyck, J, Franssen, Mtm, Sollie, K M, van der Post, Jam, Bossuyt, Pmm, Opmeer, B C, Kok, M., Mol, Bwj, and van Baaren, G-J

Published
2016

13. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women

Author

Bruijn, M. M.C., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Oei, G., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bolte, A. C., Vandenbussche, F. P.H.A., Woiski, M. D., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Kok, M., Mol, B. W.J., van Baaren, G. J., Bruijn, M. M.C., Vis, J. Y., Wilms, F. F., Oudijk, M. A., Kwee, A., Porath, M. M., Oei, G., Scheepers, H. C.J., Spaanderman, M. E.A., Bloemenkamp, K. W.M., Haak, M. C., Bolte, A. C., Vandenbussche, F. P.H.A., Woiski, M. D., Bax, C. J., Cornette, J. M.J., Duvekot, J. J., Nij Bijvanck, B. W.A., van Eyck, J., Franssen, M. T.M., Sollie, K. M., van der Post, J. A.M., Bossuyt, P. M.M., Opmeer, B. C., Kok, M., Mol, B. W.J., and van Baaren, G. J.

Abstract

Objective: To evaluate whether in symptomatic women, the combination of quantitative fetal fibronectin (fFN) testing and cervical length (CL) improves the prediction of preterm delivery (PTD) within 7 days compared with qualitative fFN and CL. Design: Post hoc analysis of frozen fFN samples of a nationwide cohort study. Setting: Ten perinatal centres in the Netherlands. Population: Symptomatic women between 24 and 34 weeks of gestation. Methods: The risk of PTD <7 days was estimated in predefined CL and fFN strata. We used logistic regression to develop a model including quantitative fFN and CL, and one including qualitative fFN (threshold 50 ng/ml) and CL. We compared the models’ capacity to identify women at low risk (<5%) for delivery within 7 days using a reclassification table. Main outcome measures: Spontaneous delivery within 7 days after study entry. Results: We studied 350 women, of whom 69 (20%) delivered within 7 days. The risk of PTD in <7 days ranged from 2% in the lowest fFN group (<10 ng/ml) to 71% in the highest group (>500 ng/ml). Multivariable logistic regression showed an increasing risk of PTD in <7 days with rising fFN concentration [10–49 ng/ml: odds ratio (OR) 1.3, 95% confidence interval (95% CI) 0.23–7.0; 50–199 ng/ml: OR 3.2, 95% CI 0.79–13; 200–499 ng/ml: OR 9.0, 95% CI 2.3–35; >500 ng/ml: OR 39, 95% CI 9.4–164] and shortening of the CL (OR 0.86 per mm, 95% CI 0.82–0.90). Use of quantitative fFN instead of qualitative fFN resulted in reclassification of 18 (5%) women from high to low risk, of whom one (6%) woman delivered within 7 days. Conclusion: In symptomatic women, quantitative fFN testing does not improve the prediction of PTD within 7 days compared with qualitative fFN testing in combination with CL measurement in terms of reclassification from high to low (<5%) risk, but it adds value across the risk range. Tweetable abstract: Quantitative fFN testing adds value to qualitative fFN testing with CL measurem

Published
2016

14. Verification and quality control of routine hematology analyzers

Author

CDL Klinisch Chemici in opleiding, Circulatory Health, LKCH Staf Patiëntenzorg, Other research (not in main researchprogram), Vis, J Y, Huisman, A, CDL Klinisch Chemici in opleiding, Circulatory Health, LKCH Staf Patiëntenzorg, Other research (not in main researchprogram), Vis, J Y, and Huisman, A

Published
2016

15. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women

Author

CDL Klinisch Chemici in opleiding, Circulatory Health, Other research (not in main researchprogram), MS Verloskunde, Bruijn, Mmc, Vis, J Y, Wilms, F F, Oudijk, M A, Kwee, A, Porath, M M, Oei, G, Scheepers, Hcj, Spaanderman, Mea, Bloemenkamp, Kwm, Haak, M C, Bolte, A C, Vandenbussche, Fpha, Woiski, M D, Bax, C J, Cornette, Jmj, Duvekot, J J, Nij Bijvanck, Bwa, van Eyck, J, Franssen, Mtm, Sollie, K M, van der Post, Jam, Bossuyt, Pmm, Opmeer, B C, Kok, M., Mol, Bwj, van Baaren, G-J, CDL Klinisch Chemici in opleiding, Circulatory Health, Other research (not in main researchprogram), MS Verloskunde, Bruijn, Mmc, Vis, J Y, Wilms, F F, Oudijk, M A, Kwee, A, Porath, M M, Oei, G, Scheepers, Hcj, Spaanderman, Mea, Bloemenkamp, Kwm, Haak, M C, Bolte, A C, Vandenbussche, Fpha, Woiski, M D, Bax, C J, Cornette, Jmj, Duvekot, J J, Nij Bijvanck, Bwa, van Eyck, J, Franssen, Mtm, Sollie, K M, van der Post, Jam, Bossuyt, Pmm, Opmeer, B C, Kok, M., Mol, Bwj, and van Baaren, G-J

Published
2016

18. Quantitative fetal fibronectin testing in combination with cervical length measurement in the prediction of spontaneous preterm delivery in symptomatic women.

Author

Bruijn M, Vis JY, Wilms FF, Oudijk MA, Kwee A, Porath MM, Oei G, Scheepers H, Spaanderman M, Bloemenkamp K, Haak MC, Bolte AC, Vandenbussche F, Woiski MD, Bax CJ, Cornette J, Duvekot JJ, Nij Bijvanck B, van Eyck J, Franssen M, Sollie KM, van der Post J, Bossuyt P, Opmeer BC, Kok M, Mol B, and van Baaren GJ

Subjects
Cervix Uteri chemistry, Cohort Studies, Female, Humans, Infant, Newborn, Obstetric Labor, Premature, Predictive Value of Tests, Premature Birth, Cervical Length Measurement, Fibronectins
Abstract

Objective: To evaluate whether in symptomatic women, the combination of quantitative fetal fibronectin (fFN) testing and cervical length (CL) improves the prediction of preterm delivery (PTD) within 7 days compared with qualitative fFN and CL., Design: Post hoc analysis of frozen fFN samples of a nationwide cohort study., Setting: Ten perinatal centres in the Netherlands., Population: Symptomatic women between 24 and 34 weeks of gestation., Methods: The risk of PTD <7 days was estimated in predefined CL and fFN strata. We used logistic regression to develop a model including quantitative fFN and CL, and one including qualitative fFN (threshold 50 ng/ml) and CL. We compared the models' capacity to identify women at low risk (<5%) for delivery within 7 days using a reclassification table., Main Outcome Measures: Spontaneous delivery within 7 days after study entry., Results: We studied 350 women, of whom 69 (20%) delivered within 7 days. The risk of PTD in <7 days ranged from 2% in the lowest fFN group (<10 ng/ml) to 71% in the highest group (>500 ng/ml). Multivariable logistic regression showed an increasing risk of PTD in <7 days with rising fFN concentration [10-49 ng/ml: odds ratio (OR) 1.3, 95% confidence interval (95% CI) 0.23-7.0; 50-199 ng/ml: OR 3.2, 95% CI 0.79-13; 200-499 ng/ml: OR 9.0, 95% CI 2.3-35; >500 ng/ml: OR 39, 95% CI 9.4-164] and shortening of the CL (OR 0.86 per mm, 95% CI 0.82-0.90). Use of quantitative fFN instead of qualitative fFN resulted in reclassification of 18 (5%) women from high to low risk, of whom one (6%) woman delivered within 7 days., Conclusion: In symptomatic women, quantitative fFN testing does not improve the prediction of PTD within 7 days compared with qualitative fFN testing in combination with CL measurement in terms of reclassification from high to low (<5%) risk, but it adds value across the risk range., Tweetable Abstract: Quantitative fFN testing adds value to qualitative fFN testing with CL measurement in the prediction of PTD., (© 2015 Royal College of Obstetricians and Gynaecologists.)

Published
2016
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results